Dexamethasone Sodium Phosphate Injection, 10 mg/mL Vial
EndocrineEssential, 95% service targetPrimary vendor Harborline Pharmaceuticals, lead 1 day, ordered every 3 days00641036725
Stock position
- On hand
- 1,660 vial22.5 days of supply
- On order
- 89 vialfirst arrives Tue Sep 15
- Forecast rate
- 73.8 vial/daynext 30 days
- Demand over 4 days
- 315 viallead time plus review period
- Safety stock
- 85 vialempirical 95th percentile of forecast error
- Reorder point
- 400 vialabove
- Stockout
- Thu Oct 8
- Recommended order
- noneby Tue Oct 6
- Inventory value
- $2,158at $1.30 per vial
How the forecast was made
Exponential smoothing15% weekly error, over-forecast21% worse than naive
A weighted recent average that learns the weekday pattern and any trend. Recent days count more than old ones.
Report card: the model was fit on history up to Tue Jul 21 and scored on the 56 days after. Weekly totals were off by 15% on average (30% day by day), and it over-forecast by 9% overall. A same-weekday-last-week guess would have been off by 12%.
actual forecast, 80% and 95% range what the model said during the report card windowvial/day
Projected on hand, vial: today's stock plus open orders on their expected dates, minus the forecast, day by day.
Lots and expiry
Earliest-expiry-first simulation against the forecast. Waste is what remains in a lot on its expiry date.
| Lot | Quantity | Expires | Days | Unit cost | Projected waste |
|---|---|---|---|---|---|
| L00105 | 1,660 | Thu May 20 | 248 | $1.30 | 0 vial · $0 |
Vendors and prices, last 90 days
| Vendor | Part number | Vendor description | Sells by | Paid per vial | Invoices | 90-day spend | Pairing |
|---|---|---|---|---|---|---|---|
| Harborline Pharmaceuticals | 00641036725 | DEXAMETHASONE NA PHOSPHATE 10 MG/ML VIAL EA | EA of 1 | $1.16 | 32 | $7,676 | stand-in |
| Summit Clinical Products | SC-409852 | DEXAME 10 SDV 1CT | EA of 1 | $1.19 | 7 | $793 | stand-in |